An Open-label, Two-period, Fixed-sequence Trial to Evaluate the Effect of Multiple Doses of BI 10773 on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Healthy Premenopausal Female Volunteers.
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2014
At a glance
- Drugs Empagliflozin (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Diabetes mellitus; Pregnancy
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 27 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Apr 2011 New trial record